Metabolomic profiles of cartilage and bone reflect tissue type, radiography-confirmed osteoarthritis, and spatial location within the joint.

Articular cartilage Bone Hip Metabolism Osteoarthritis

Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
13 Feb 2024
Historique:
received: 16 11 2023
revised: 09 02 2024
accepted: 12 02 2024
medline: 20 2 2024
pubmed: 20 2 2024
entrez: 19 2 2024
Statut: aheadofprint

Résumé

Osteoarthritis is the most common chronic joint disease, characterized by the abnormal remodeling of joint tissues including articular cartilage and subchondral bone. However, there are currently no therapeutic drug targets to slow the progression of disease because disease pathogenesis is largely unknown. Thus, the goals of this study were to identify metabolic differences between articular cartilage and subchondral bone, compare the metabolic shifts in osteoarthritic grade III and IV tissues, and spatially map metabolic shifts across regions of osteoarthritic hip joints. Articular cartilage and subchondral bone from 9 human femoral heads were obtained after total joint arthroplasty, homogenized and metabolites were extracted for liquid chromatography-mass spectrometry analysis. Metabolomic profiling revealed that distinct metabolic endotypes exist between osteoarthritic tissues, late-stage grades, and regions of the diseased joint. The pathways that contributed the most to these differences between tissues were associated with lipid and amino acid metabolism. Differences between grades were associated with nucleotide, lipid, and sugar metabolism. Specific metabolic pathways such as glycosaminoglycan degradation and amino acid metabolism, were spatially constrained to more superior regions of the femoral head. These results suggest that radiography-confirmed grades III and IV osteoarthritis are associated with distinct global metabolic and that metabolic shifts are not uniform across the joint. The results of this study enhance our understanding of osteoarthritis pathogenesis and may lead to potential drug targets to slow, halt, or reverse tissue damage in late stages of osteoarthritis.

Identifiants

pubmed: 38373382
pii: S0006-291X(24)00219-5
doi: 10.1016/j.bbrc.2024.149683
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

149683

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hope D Welhaven (HD)

Department of Chemistry & Biochemistry, Montana State University, Bozeman, MT, 59717, United States. Electronic address: hopewelhaven@msu.montana.edu.

Ethan Viles (E)

Department of Mechanical & Industrial Engineering, Montana State University, Bozeman, MT, 59717, United States. Electronic address: ethan.viles@montana.edu.

Jenna Starke (J)

Montana WWAMI, University of Washington School of Medicine, Seattle, WA, 98195, United States. Electronic address: jennamstarke@gmail.com.

Cameron Wallace (C)

Department of Orthopaedic Surgery, University of Utah Health, Salt Lake City, UT, 84103, United States. Electronic address: c33wallace@gmail.com.

Brian Bothner (B)

Department of Chemistry & Biochemistry, Montana State University, Bozeman, MT, 59717, United States. Electronic address: bbothner@montana.edu.

Ronald K June (RK)

Department of Mechanical & Industrial Engineering, Montana State University, Bozeman, MT, 59717, United States. Electronic address: rjune@montana.edu.

Alyssa K Hahn (AK)

Department of Biological and Environmental Sciences, Carroll College, Helena, MT, 59625, United States. Electronic address: alyssahahn19@gmail.com.

Classifications MeSH